Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01502982
What this trial is testing

Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Nordic Lymphoma Group 160
Large-scale testing (Phase 3)Study completedNCT00590785
What this trial is testing

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

Who this might be right for
High RiskBreast CancerPositive Nodes+2 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Looking for participantsNCT06830421
What this trial is testing

Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

Who this might be right for
Primary Central Nervous System Lymphoma
University Hospital Freiburg 340
Large-scale testing (Phase 3)UnknownNCT00435955
What this trial is testing

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Azienda Ospedaliera San Giovanni Battista 240
Testing effectiveness (Phase 2)Study completedNCT00017368
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Oncology Group 42
Post-approval studies (Phase 4)UnknownNCT02024308
What this trial is testing

AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy

Who this might be right for
Acute Myeloid LeukemiaAML1-ETO Fusion Protein Expression
Changhai Hospital 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04443348
What this trial is testing

Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

Who this might be right for
Triple Negative Breast CancerHormone Receptor Positive (HR+), HER2-negative Breast CancerBiopsy-proven, Positive Lymph Node(s)
Laura M. Spring, MD 120
Not applicableStudy completedNCT01809717
What this trial is testing

Multiple Myeloma and Exercise

Who this might be right for
Newly Diagnosed Multiple Myeloma
Abramson Cancer Center at Penn Medicine 10
Not applicableStudy completedNCT00031668
What this trial is testing

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 6
Testing effectiveness (Phase 2)Study completedNCT00004132
What this trial is testing

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+3 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT02199236
What this trial is testing

Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

Who this might be right for
Rectal or Anal Cancer
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT06652048
What this trial is testing

High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI

Who this might be right for
Non-Small Cell Lung Cancer
Jialei Wang 60
Large-scale testing (Phase 3)Ended earlyNCT00249899
What this trial is testing

Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Takeda 649
Testing effectiveness (Phase 2)Study completedNCT01375777
What this trial is testing

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

Who this might be right for
Hyperlipidemia
Amgen 411
Early research (Phase 1)Study completedNCT02573363
What this trial is testing

Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Chicago 25
Testing effectiveness (Phase 2)Ended earlyNCT00240162
What this trial is testing

PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 21
Early research (Phase 1)Study completedNCT00003080
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06418789
What this trial is testing

High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors

Who this might be right for
Germ Cell Tumor
N.N. Petrov National Medical Research Center of Oncology 25
Testing effectiveness (Phase 2)UnknownNCT00002627
What this trial is testing

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
St. Louis University 30
Testing effectiveness (Phase 2)Study completedNCT02416206
What this trial is testing

High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Northside Hospital, Inc. 65
Next Page